VISINE MULTI-SYMPTOM
VISINE MULTI-SYMPTOM
Approved
DIN Number
02338602
Drug Class
Human
Market Date
Mar 21, 2012
Company
HC
johnson & johnson inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02338602
AIG Number0214226001
Classification & Schedule
C
Drug Class
Human
S
Schedule
OTC
A
ATC Code
S01GA52 TETRYZOLINE, COMBINATIONS
Product Specifications
Dosage FormDrops
Route of AdministrationOphthalmic
AHFS Classification52:32.00
Health Canada Classification
ACTIVE INGREDIENTS (2)
TETRAHYDROZOLINE HYDROCHLORIDEActive
Strength: 0.05 % / W/V
Monograph: TETRAHYDROZOLINE HYDROCHLORIDE
ZINC SULFATEActive
Strength: 0.25 % / W/V
Monograph: ZINC SULFATE